Considerations for radiotherapy planning with MV photons using dose-to-medium

[1]  S. Petit,et al.  Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study. , 2022, Oral oncology.

[2]  E. Moros,et al.  Maintaining dosimetric quality when switching to a Monte Carlo dose engine for head and neck volumetric‐modulated arc therapy planning , 2022, Journal of applied clinical medical physics.

[3]  V. Hernandez,et al.  Impact of the dose quantity used in MV photon optimization on dose distribution, robustness and complexity. , 2021, Medical physics.

[4]  C. Fuller,et al.  Normal Tissue Complication Probability (NTCP) Prediction Model for Osteoradionecrosis of the Mandible in Patients With Head and Neck Cancer After Radiation Therapy: Large-Scale Observational Cohort , 2021, International journal of radiation oncology, biology, physics.

[5]  D. Followill,et al.  Report dose-to-medium in clinical trials where available; a consensus from the global Harmonisation group to maximize consistency. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Ana Vaniqui,et al.  What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Joan Carles Vilanova,et al.  A new dose quantity for evaluation and optimisation of MV photon dose distributions when using advanced algorithms: proof of concept and potential applications , 2020, Physics in medicine and biology.

[8]  R. Sasaki,et al.  Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma , 2020, Radiation oncology.

[9]  Tommy Knöös,et al.  AAPM Task Group 329: Reference dose specification for dose calculations: dose-to-water or dose-to-muscle? , 2019, Medical physics.

[10]  C. Hansen,et al.  Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations , 2019, Acta oncologica.

[11]  David D Taylor,et al.  Dose to medium in head and neck radiotherapy: Clinical implications for target volume metrics , 2019, Physics and imaging in radiation oncology.

[12]  Wei Liu,et al.  Robust radiotherapy planning , 2018, Physics in medicine and biology.

[13]  J. Vilanova,et al.  Dosimetric impact of Acuros XB dose-to-water and dose-to-medium reporting modes on VMAT planning for head and neck cancer. , 2018, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[14]  Iwan Kawrakow,et al.  On the conversion of dose to bone to dose to water in radiotherapy treatment planning systems , 2018, Physics and imaging in radiation oncology.

[15]  Nader A. Elsherbini,et al.  AAA and AXB algorithms for the treatment of nasopharyngeal carcinoma using IMRT and RapidArc techniques. , 2017, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[16]  Jan Seuntjens,et al.  Fundamentals of Ionizing Radiation Dosimetry , 2017 .

[17]  E. Sterpin.  Potential pitfalls of the PTV concept in dose-to-medium planning optimization. , 2016, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[18]  Indrin J Chetty,et al.  Dose Specification for NRG Radiation Therapy Trials. , 2016, International journal of radiation oncology, biology, physics.

[19]  Pedro Andreo,et al.  Dose to ‘water-like’ media or dose to tissue in MV photons radiotherapy treatment planning: still a matter of debate , 2015, Physics in medicine and biology.

[20]  C-M Ma,et al.  Dose specification for radiation therapy: dose to water or dose to medium? , 2011, Physics in medicine and biology.

[21]  Melvin L. Griem,et al.  Prescribing, Recording, and Reporting Photon Beam Therapy , 1994 .

[22]  J. Galvin,et al.  Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases. , 2017, International journal of radiation oncology, biology, physics.

[23]  Ryan S. Lee,et al.  The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience. , 2017, Oral oncology.